3 active warrant series covering 5,876,800 shares (~6% potential dilution); nearest expiry 2026-12-30.
| Type | Status | Source | |||||
|---|---|---|---|---|---|---|---|
| warrant | $0.30 | Dec 30, 2026* 104d | 1.7M | OTM | 1.7% | C$516K | Auto |
| warrant | $0.25 | Jan 24, 2027 129d | 149K | OTM | 0.2% | C$37K | Auto |
| warrant | $0.30 | Jan 24, 2027 129d | 4.0M | OTM | 4.1% | C$1.2M | Auto |
Basis: Current shares & price vs as-filed warrant terms.
5 option grants covering 3,041,667 shares (~3.1% potential dilution). Counted apart from the warrants above.
| Type | Status | Source | |||||
|---|---|---|---|---|---|---|---|
| option | $0.75 | Dec 31, 2026 105d | 42K | OTM | 0.0% | C$31K | Auto |
| option | $0.40 | Aug 22, 2027 339d | 150K | OTM | 0.2% | C$60K | Auto |
| option | $0.15 | May 10, 2028 601d | 850K | OTM | 0.9% | C$128K | Auto |
| option | $0.15 | Apr 25, 2029 951d | 1.5M | OTM | 1.5% | C$225K | Auto |
| option | $0.25 | Mar 31, 2030 1291d | 500K | OTM | 0.5% | C$125K | Auto |
98,435,017 shares outstanding, plus 5,876,800 from warrants and 3,041,667 from options — a fully diluted 107,353,484 shares, or ~9.1% above today's count if every one of them is exercised.
Price history with the company's supply walls overlaid — warrants (amber), employee and consultant options (pink), and free-trading unlock dates (violet). Each wall sits at the price the paper is struck at today, restated through any consolidation, and is measured in the SHARES it can issue rather than the number of certificates. Levels and dates are Pacific Time.
3 active warrant series covering 5,876,800 shares (~6% potential dilution); nearest expiry 2026-12-30.
| Type | Status | Source | |||||
|---|---|---|---|---|---|---|---|
| warrant | $0.30 | Dec 30, 2026* 104d | 1.7M | OTM | 1.7% | C$516K | Auto |
| warrant | $0.25 | Jan 24, 2027 129d | 149K | OTM | 0.2% | C$37K | Auto |
| warrant | $0.30 | Jan 24, 2027 129d | 4.0M | OTM | 4.1% | C$1.2M | Auto |
Basis: Current shares & price vs as-filed warrant terms.
5 option grants covering 3,041,667 shares (~3.1% potential dilution). Counted apart from the warrants above.
| Type | Status | Source | |||||
|---|---|---|---|---|---|---|---|
| option | $0.75 | Dec 31, 2026 105d | 42K | OTM | 0.0% | C$31K | Auto |
| option | $0.40 | Aug 22, 2027 339d | 150K | OTM | 0.2% | C$60K | Auto |
| option | $0.15 | May 10, 2028 601d | 850K | OTM | 0.9% | C$128K | Auto |
| option | $0.15 | Apr 25, 2029 951d | 1.5M | OTM | 1.5% | C$225K | Auto |
| option | $0.25 | Mar 31, 2030 1291d | 500K | OTM | 0.5% | C$125K | Auto |
98,435,017 shares outstanding, plus 5,876,800 from warrants and 3,041,667 from options — a fully diluted 107,353,484 shares, or ~9.1% above today's count if every one of them is exercised.
Price history with the company's supply walls overlaid — warrants (amber), employee and consultant options (pink), and free-trading unlock dates (violet). Each wall sits at the price the paper is struck at today, restated through any consolidation, and is measured in the SHARES it can issue rather than the number of certificates. Levels and dates are Pacific Time.
An issuer that discloses only a plan total appears as one line at its weighted-average exercise price and weighted-average remaining life — the filing's own summary, not a per-grant schedule.
An issuer that discloses only a plan total appears as one line at its weighted-average exercise price and weighted-average remaining life — the filing's own summary, not a per-grant schedule.
